BlackRock, Inc. 13D and 13G filings for Cullinan Oncology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-08 2:17 pm Unchanged |
2024-09-30 | 13G | Cullinan Oncology, Inc. CGEM |
BlackRock Inc. BLK |
4,338,725 7.500% |
0 (Unchanged) |
Filing |
| 2024-10-22 3:24 pm Purchase |
2024-09-30 | 13G | Cullinan Oncology, Inc. CGEM |
BlackRock Inc. BLK |
4,338,725 7.500% |
1,589,995 (+57.84%) |
Filing |
| 2024-06-07 1:30 pm Purchase |
2024-05-31 | 13G | Cullinan Oncology, Inc. CGEM |
BlackRock Inc. BLK |
2,748,730 4.800% |
286,456 (+11.63%) |
Filing |
| 2024-01-29 5:25 pm Purchase |
2023-12-31 | 13G | Cullinan Oncology, Inc. CGEM |
BlackRock Inc. BLK |
2,462,274 5.800% |
425,623 (+20.90%) |
Filing |
| 2023-09-07 09:38 am Sale |
2023-08-31 | 13G | Cullinan Oncology, Inc. CGEM |
BlackRock Inc. BLK |
2,036,651 4.800% |
-469,564 (-18.74%) |
Filing |
| 2023-02-03 12:10 pm Purchase |
2022-12-31 | 13G | Cullinan Oncology, Inc. CGEM |
BlackRock Inc. BLK |
2,506,215 5.500% |
2,506,215 (New Position) |
Filing |